KKR has announced the closing of a new $1.45 billion fund, the KKR Health Care Strategic Growth Fund.
As its name suggests, the fund is dedicated to healthcare growth equity investment opportunities, specifically within the Americas.
KKR stated that the fund will seek to make investments of up to $100 million, focusing on themes such as clinical/technological innovation, cost containment and consolidation of therapeutic offerings or care providers.
Kohlberg Kravis Roberts (KKR) & Co., based in New York, considers investments in all industries, including healthcare. The firm is publicly traded under the ticker symbol KKR. It prefers to invest in a range of debt and public equity investing and may co-invest, seeking a controlling ownership of a company or a strategic minority positions.
